

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.10799714 |
| 2 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.74842425 |
| 3 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.48950809 |
| 4 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.47353001 |
| 5 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.45422526 |
| 6 | GDP-mannose metabolic process (GO:0019673) | 4.41614410 |
| 7 | establishment of integrated proviral latency (GO:0075713) | 4.40266956 |
| 8 | negative regulation of ligase activity (GO:0051352) | 4.32348273 |
| 9 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.32348273 |
| 10 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.31814373 |
| 11 | establishment of viral latency (GO:0019043) | 4.29811103 |
| 12 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.27785945 |
| 13 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.25667474 |
| 14 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.25667474 |
| 15 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.25667474 |
| 16 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.25665708 |
| 17 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.25665708 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.21873669 |
| 19 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.14126548 |
| 20 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.14126548 |
| 21 | protein maturation by protein folding (GO:0022417) | 4.10822844 |
| 22 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.08463418 |
| 23 | ribosome assembly (GO:0042255) | 3.99331441 |
| 24 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.81189693 |
| 25 | * dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.72474138 |
| 26 | rRNA modification (GO:0000154) | 3.72096455 |
| 27 | endosome to melanosome transport (GO:0035646) | 3.70641452 |
| 28 | endosome to pigment granule transport (GO:0043485) | 3.70641452 |
| 29 | positive regulation of ligase activity (GO:0051351) | 3.66095011 |
| 30 | maturation of 5.8S rRNA (GO:0000460) | 3.62047514 |
| 31 | purine nucleobase biosynthetic process (GO:0009113) | 3.60465755 |
| 32 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.54830704 |
| 33 | IMP biosynthetic process (GO:0006188) | 3.53272154 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.50430344 |
| 35 | viral mRNA export from host cell nucleus (GO:0046784) | 3.49652341 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 3.47008196 |
| 37 | tRNA aminoacylation for protein translation (GO:0006418) | 3.45437701 |
| 38 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.45399769 |
| 39 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.42200172 |
| 40 | cullin deneddylation (GO:0010388) | 3.37619415 |
| 41 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.36157049 |
| 42 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.36157049 |
| 43 | tricarboxylic acid cycle (GO:0006099) | 3.34273260 |
| 44 | protein deneddylation (GO:0000338) | 3.33241012 |
| 45 | nucleobase biosynthetic process (GO:0046112) | 3.31246082 |
| 46 | regulation of ligase activity (GO:0051340) | 3.31184580 |
| 47 | amino acid activation (GO:0043038) | 3.31183680 |
| 48 | tRNA aminoacylation (GO:0043039) | 3.31183680 |
| 49 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.28701950 |
| 50 | regulation of cellular amine metabolic process (GO:0033238) | 3.26704469 |
| 51 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.25828989 |
| 52 | signal peptide processing (GO:0006465) | 3.23192393 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.22802299 |
| 54 | L-phenylalanine metabolic process (GO:0006558) | 3.22802299 |
| 55 | mannosylation (GO:0097502) | 3.20541167 |
| 56 | COPI coating of Golgi vesicle (GO:0048205) | 3.19909950 |
| 57 | Golgi transport vesicle coating (GO:0048200) | 3.19909950 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.19776916 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 3.17989587 |
| 60 | negative regulation of sterol transport (GO:0032372) | 3.17989587 |
| 61 | positive regulation of cell cycle arrest (GO:0071158) | 3.17660834 |
| 62 | L-phenylalanine catabolic process (GO:0006559) | 3.15037512 |
| 63 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.15037512 |
| 64 | mitotic nuclear envelope disassembly (GO:0007077) | 3.14438480 |
| 65 | rRNA methylation (GO:0031167) | 3.08459837 |
| 66 | mitotic sister chromatid segregation (GO:0000070) | 3.07398423 |
| 67 | negative regulation of protein ubiquitination (GO:0031397) | 3.06657593 |
| 68 | reverse cholesterol transport (GO:0043691) | 2.99995173 |
| 69 | DNA replication checkpoint (GO:0000076) | 2.98026844 |
| 70 | chaperone-mediated protein transport (GO:0072321) | 2.97934383 |
| 71 | sulfur amino acid catabolic process (GO:0000098) | 2.97044285 |
| 72 | aromatic amino acid family catabolic process (GO:0009074) | 2.95926250 |
| 73 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.93885961 |
| 74 | nuclear envelope disassembly (GO:0051081) | 2.91441123 |
| 75 | membrane disassembly (GO:0030397) | 2.91441123 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 2.91042655 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 2.91042655 |
| 78 | macromolecular complex remodeling (GO:0034367) | 2.91042655 |
| 79 | signal transduction in response to DNA damage (GO:0042770) | 2.90985233 |
| 80 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.90907019 |
| 81 | valine metabolic process (GO:0006573) | 2.89904321 |
| 82 | one-carbon metabolic process (GO:0006730) | 2.89258684 |
| 83 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.89189307 |
| 84 | termination of RNA polymerase III transcription (GO:0006386) | 2.87337042 |
| 85 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.87337042 |
| 86 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.87028819 |
| 87 | spliceosomal snRNP assembly (GO:0000387) | 2.86072552 |
| 88 | IMP metabolic process (GO:0046040) | 2.85872966 |
| 89 | pseudouridine synthesis (GO:0001522) | 2.83600842 |
| 90 | protein retention in ER lumen (GO:0006621) | 2.83480987 |
| 91 | DNA deamination (GO:0045006) | 2.83390872 |
| 92 | lipopolysaccharide metabolic process (GO:0008653) | 2.82743139 |
| 93 | protein carboxylation (GO:0018214) | 2.82363108 |
| 94 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82363108 |
| 95 | complement activation, alternative pathway (GO:0006957) | 2.82265189 |
| 96 | disruption of cells of other organism (GO:0044364) | 2.80846410 |
| 97 | killing of cells of other organism (GO:0031640) | 2.80846410 |
| 98 | regulation of mitochondrial translation (GO:0070129) | 2.79623721 |
| 99 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.79406986 |
| 100 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.79406986 |
| 101 | cell cycle G1/S phase transition (GO:0044843) | 2.78962887 |
| 102 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.78962887 |
| 103 | tryptophan catabolic process (GO:0006569) | 2.78273653 |
| 104 | indole-containing compound catabolic process (GO:0042436) | 2.78273653 |
| 105 | indolalkylamine catabolic process (GO:0046218) | 2.78273653 |
| 106 | nuclear pore organization (GO:0006999) | 2.77579706 |
| 107 | peptidyl-histidine modification (GO:0018202) | 2.75521509 |
| 108 | formation of translation preinitiation complex (GO:0001731) | 2.73459259 |
| 109 | respiratory chain complex IV assembly (GO:0008535) | 2.72683676 |
| 110 | DNA ligation (GO:0006266) | 2.72150913 |
| 111 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.72141435 |
| 112 | oxidative phosphorylation (GO:0006119) | 2.71831342 |
| 113 | NADH metabolic process (GO:0006734) | 2.71625677 |
| 114 | regulation of protein activation cascade (GO:2000257) | 2.71351651 |
| 115 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.71165834 |
| 116 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.69221441 |
| 117 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.69221441 |
| 118 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.68457819 |
| 119 | sequestering of metal ion (GO:0051238) | 2.67874255 |
| 120 | aldehyde catabolic process (GO:0046185) | 2.67751275 |
| 121 | regulation of translational fidelity (GO:0006450) | 2.67673347 |
| 122 | tryptophan metabolic process (GO:0006568) | 2.67453541 |
| 123 | regulation of cell cycle arrest (GO:0071156) | 2.67155947 |
| 124 | glycine metabolic process (GO:0006544) | 2.67122239 |
| 125 | proline biosynthetic process (GO:0006561) | 2.66587429 |
| 126 | kynurenine metabolic process (GO:0070189) | 2.65596966 |
| 127 | L-serine metabolic process (GO:0006563) | 2.64647726 |
| 128 | mitotic metaphase plate congression (GO:0007080) | 2.64316691 |
| 129 | nuclear envelope reassembly (GO:0031468) | 2.62382063 |
| 130 | mitotic nuclear envelope reassembly (GO:0007084) | 2.62382063 |
| 131 | protein targeting to mitochondrion (GO:0006626) | 2.61869739 |
| 132 | negative regulation of fibrinolysis (GO:0051918) | 2.61595599 |
| 133 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.61591900 |
| 134 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.61253508 |
| 135 | branched-chain amino acid catabolic process (GO:0009083) | 2.61133869 |
| 136 | regulation of complement activation (GO:0030449) | 2.60705559 |
| 137 | nucleoside salvage (GO:0043174) | 2.60402249 |
| 138 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.59665614 |
| 139 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.59288906 |
| 140 | galactose catabolic process (GO:0019388) | 2.58084262 |
| 141 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.57034013 |
| 142 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.57034013 |
| 143 | tetrahydrofolate metabolic process (GO:0046653) | 2.56439013 |
| 144 | glyoxylate metabolic process (GO:0046487) | 2.55202447 |
| 145 | purine-containing compound salvage (GO:0043101) | 2.54878921 |
| 146 | 4-hydroxyproline metabolic process (GO:0019471) | 2.50679891 |
| 147 | exocrine pancreas development (GO:0031017) | 2.49063665 |
| 148 | complement activation, classical pathway (GO:0006958) | 2.47020293 |
| 149 | blood coagulation, intrinsic pathway (GO:0007597) | 2.46826275 |
| 150 | opsonization (GO:0008228) | 2.44698963 |
| 151 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.44096206 |
| 152 | regulation of cholesterol metabolic process (GO:0090181) | 2.43735105 |
| 153 | bile acid biosynthetic process (GO:0006699) | 2.43503997 |
| 154 | maturation of SSU-rRNA (GO:0030490) | 2.42982300 |
| 155 | plasma lipoprotein particle clearance (GO:0034381) | 2.41311274 |
| 156 | cysteine metabolic process (GO:0006534) | 2.40773990 |
| 157 | histone-serine phosphorylation (GO:0035404) | 2.39406007 |
| 158 | alpha-linolenic acid metabolic process (GO:0036109) | 2.38991011 |
| 159 | complement activation (GO:0006956) | 2.37551799 |
| 160 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.37346905 |
| 161 | low-density lipoprotein particle remodeling (GO:0034374) | 2.37017694 |
| 162 | imidazole-containing compound metabolic process (GO:0052803) | 2.35513018 |
| 163 | protein activation cascade (GO:0072376) | 2.35188571 |
| 164 | reactive oxygen species biosynthetic process (GO:1903409) | 2.35108589 |
| 165 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.33365583 |
| 166 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.32439593 |
| 167 | serine family amino acid biosynthetic process (GO:0009070) | 2.31690114 |
| 168 | defense response to fungus (GO:0050832) | 2.31462718 |
| 169 | folic acid metabolic process (GO:0046655) | 2.31152509 |
| 170 | platelet dense granule organization (GO:0060155) | 2.30321580 |
| 171 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.29975175 |
| 172 | amino-acid betaine metabolic process (GO:0006577) | 2.29525338 |
| 173 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.29126291 |
| 174 | phospholipid efflux (GO:0033700) | 2.28777539 |
| 175 | plasma lipoprotein particle organization (GO:0071827) | 2.28713183 |
| 176 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.27908946 |
| 177 | regulation of lipoprotein particle clearance (GO:0010984) | 2.27907346 |
| 178 | folic acid-containing compound metabolic process (GO:0006760) | 2.27255673 |
| 179 | folic acid transport (GO:0015884) | 2.26281341 |
| 180 | pteridine-containing compound metabolic process (GO:0042558) | 2.25224053 |
| 181 | regulation of fibrinolysis (GO:0051917) | 2.24936061 |
| 182 | purine nucleotide salvage (GO:0032261) | 2.24690786 |
| 183 | regulation of cholesterol esterification (GO:0010872) | 2.24534041 |
| 184 | negative regulation of phagocytosis (GO:0050765) | 2.22949295 |
| 185 | cotranslational protein targeting to membrane (GO:0006613) | 2.21003132 |
| 186 | protein targeting to ER (GO:0045047) | 2.20326181 |
| 187 | DNA strand elongation (GO:0022616) | 2.19700518 |
| 188 | urea cycle (GO:0000050) | 2.17604962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.31568247 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.72203817 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.42080362 |
| 4 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.02444854 |
| 5 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.77512431 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72593617 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.71260236 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.67480974 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.63783970 |
| 10 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.52594961 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.49653635 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.47764303 |
| 13 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29218226 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.22786814 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.19923451 |
| 16 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.17315003 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.17150617 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.14162312 |
| 19 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.11486968 |
| 20 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.09148925 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08095484 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07284782 |
| 23 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.03482147 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00313075 |
| 25 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.95170269 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91747668 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88279787 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.84556937 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79150681 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77435731 |
| 31 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.76146458 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75980993 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.75737702 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.72309667 |
| 35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.71809179 |
| 36 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71363167 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71058231 |
| 38 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.69856284 |
| 39 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.68034373 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65805980 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.65657999 |
| 42 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.61243977 |
| 43 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.58272646 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.57300948 |
| 45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57170249 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57123765 |
| 47 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.57008603 |
| 48 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.54765904 |
| 49 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54280191 |
| 50 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53076906 |
| 51 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.53075702 |
| 52 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51213075 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50879342 |
| 54 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50738814 |
| 55 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.49356629 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.49259675 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.48934930 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48602542 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47909257 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47048797 |
| 61 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44648955 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44128059 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.44083063 |
| 64 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43589475 |
| 65 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.43333281 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.41764789 |
| 67 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.40885238 |
| 68 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40645992 |
| 69 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40385914 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.38759294 |
| 71 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38068781 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36296507 |
| 73 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.35931106 |
| 74 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.35755825 |
| 75 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33910872 |
| 76 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31110613 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29129001 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27600467 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27096619 |
| 80 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.26702284 |
| 81 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26393703 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25935621 |
| 83 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25396044 |
| 84 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24189785 |
| 85 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.21611988 |
| 86 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20023614 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19543758 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17404335 |
| 89 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17088439 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16911839 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16613614 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16292484 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15875609 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15371190 |
| 95 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15237853 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13386809 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09951595 |
| 98 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.09694714 |
| 99 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08261586 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08148900 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07963428 |
| 102 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07232387 |
| 103 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06789564 |
| 104 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.06281564 |
| 105 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05634870 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05486691 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04994270 |
| 108 | MYB_26560356_Chip-Seq_TH2_Human | 1.04665973 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03602014 |
| 110 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03007287 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02448006 |
| 112 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01457990 |
| 113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00865823 |
| 114 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99462498 |
| 115 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99204127 |
| 116 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98452535 |
| 117 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97953689 |
| 118 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97804034 |
| 119 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97547458 |
| 120 | * ELF5_23300383_ChIP-Seq_T47D_Human | 0.96670307 |
| 121 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96449026 |
| 122 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96361640 |
| 123 | MYB_26560356_Chip-Seq_TH1_Human | 0.96157391 |
| 124 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95662916 |
| 125 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.95379955 |
| 126 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95094310 |
| 127 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95055384 |
| 128 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94643261 |
| 129 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94086867 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93562098 |
| 131 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89137821 |
| 132 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.86597375 |
| 133 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.83700003 |
| 134 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83611429 |
| 135 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.81172520 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.77983029 |
| 137 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77938822 |
| 138 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.75993175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008058_abnormal_DNA_repair | 4.12238107 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.87470404 |
| 3 | MP0009840_abnormal_foam_cell | 3.49419628 |
| 4 | MP0005365_abnormal_bile_salt | 3.36060533 |
| 5 | MP0005360_urolithiasis | 3.26309681 |
| 6 | MP0003718_maternal_effect | 3.13331944 |
| 7 | MP0005408_hypopigmentation | 3.10960437 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.08889637 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.46806450 |
| 10 | MP0008932_abnormal_embryonic_tissue | 2.29828316 |
| 11 | MP0003436_decreased_susceptibility_to | 2.29155895 |
| 12 | MP0006054_spinal_hemorrhage | 2.22428648 |
| 13 | * MP0003693_abnormal_embryo_hatching | 2.18672623 |
| 14 | MP0005083_abnormal_biliary_tract | 2.17948144 |
| 15 | MP0003941_abnormal_skin_development | 2.14409077 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.12998820 |
| 17 | MP0003786_premature_aging | 2.12858791 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.06861586 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.96526641 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.93600281 |
| 21 | MP0002396_abnormal_hematopoietic_system | 1.87019401 |
| 22 | MP0010329_abnormal_lipoprotein_level | 1.81508441 |
| 23 | MP0001730_embryonic_growth_arrest | 1.77358192 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.73960168 |
| 25 | MP0003186_abnormal_redox_activity | 1.72825303 |
| 26 | MP0005395_other_phenotype | 1.68349203 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.66813705 |
| 28 | MP0002419_abnormal_innate_immunity | 1.62335228 |
| 29 | MP0001881_abnormal_mammary_gland | 1.61542879 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.61534641 |
| 31 | MP0005025_abnormal_response_to | 1.60392131 |
| 32 | MP0009697_abnormal_copulation | 1.58996995 |
| 33 | MP0003724_increased_susceptibility_to | 1.58278904 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.57744592 |
| 35 | MP0009785_altered_susceptibility_to | 1.56349760 |
| 36 | MP0005332_abnormal_amino_acid | 1.55009992 |
| 37 | MP0000358_abnormal_cell_content/ | 1.54359641 |
| 38 | MP0001853_heart_inflammation | 1.54141808 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.52731371 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.50926999 |
| 41 | MP0000609_abnormal_liver_physiology | 1.50923760 |
| 42 | MP0001764_abnormal_homeostasis | 1.49805079 |
| 43 | MP0002736_abnormal_nociception_after | 1.48909669 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.47772581 |
| 45 | MP0004147_increased_porphyrin_level | 1.47375294 |
| 46 | MP0005451_abnormal_body_composition | 1.43145082 |
| 47 | MP0002006_tumorigenesis | 1.40420171 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.38410129 |
| 49 | MP0003252_abnormal_bile_duct | 1.33625338 |
| 50 | MP0000343_altered_response_to | 1.33489293 |
| 51 | MP0001529_abnormal_vocalization | 1.33454748 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.33286150 |
| 53 | MP0002796_impaired_skin_barrier | 1.30628468 |
| 54 | MP0008469_abnormal_protein_level | 1.30033796 |
| 55 | MP0000598_abnormal_liver_morphology | 1.28867421 |
| 56 | MP0000490_abnormal_crypts_of | 1.27885237 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.27737592 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 1.27273860 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.25507976 |
| 60 | MP0000685_abnormal_immune_system | 1.24708164 |
| 61 | MP0002254_reproductive_system_inflammat | 1.23027984 |
| 62 | MP0005380_embryogenesis_phenotype | 1.22938169 |
| 63 | MP0001672_abnormal_embryogenesis/_devel | 1.22938169 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.22550274 |
| 65 | MP0000350_abnormal_cell_proliferation | 1.21404666 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.19753832 |
| 67 | MP0005501_abnormal_skin_physiology | 1.19717918 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.19484738 |
| 69 | MP0002938_white_spotting | 1.19209875 |
| 70 | * MP0002080_prenatal_lethality | 1.19073299 |
| 71 | MP0001697_abnormal_embryo_size | 1.18382365 |
| 72 | MP0002452_abnormal_antigen_presenting | 1.17592495 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.15748493 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.13183555 |
| 75 | MP0001800_abnormal_humoral_immune | 1.11816298 |
| 76 | MP0003984_embryonic_growth_retardation | 1.10147297 |
| 77 | MP0000313_abnormal_cell_death | 1.10055352 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 1.09579952 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.09287168 |
| 80 | MP0004019_abnormal_vitamin_homeostasis | 1.09059984 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.08981076 |
| 82 | MP0001819_abnormal_immune_cell | 1.08844931 |
| 83 | MP0003195_calcinosis | 1.08629508 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 1.08431197 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.08341976 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 1.08341976 |
| 87 | MP0000858_altered_metastatic_potential | 1.08229296 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 1.08130952 |
| 89 | MP0002723_abnormal_immune_serum | 1.07385646 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 1.06268781 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 1.05500042 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 1.04034234 |
| 93 | MP0009763_increased_sensitivity_to | 1.04017902 |
| 94 | MP0008007_abnormal_cellular_replicative | 1.03714697 |
| 95 | MP0002398_abnormal_bone_marrow | 1.02690335 |
| 96 | MP0002405_respiratory_system_inflammati | 1.02492103 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 1.02191920 |
| 98 | MP0002088_abnormal_embryonic_growth/wei | 1.01783026 |
| 99 | MP0005058_abnormal_lysosome_morphology | 1.00608439 |
| 100 | MP0000249_abnormal_blood_vessel | 0.99721754 |
| 101 | MP0009764_decreased_sensitivity_to | 0.99602973 |
| 102 | MP0002429_abnormal_blood_cell | 0.97878949 |
| 103 | MP0001790_abnormal_immune_system | 0.97697582 |
| 104 | MP0005387_immune_system_phenotype | 0.97697582 |
| 105 | MP0001873_stomach_inflammation | 0.97094504 |
| 106 | MP0005165_increased_susceptibility_to | 0.96760700 |
| 107 | MP0010094_abnormal_chromosome_stability | 0.95827988 |
| 108 | MP0008057_abnormal_DNA_replication | 0.94962058 |
| 109 | MP0000689_abnormal_spleen_morphology | 0.94367799 |
| 110 | MP0003077_abnormal_cell_cycle | 0.93879516 |
| 111 | MP0005671_abnormal_response_to | 0.92784337 |
| 112 | MP0005023_abnormal_wound_healing | 0.92717294 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.92619673 |
| 114 | MP0000716_abnormal_immune_system | 0.92253322 |
| 115 | MP0003868_abnormal_feces_composition | 0.92103980 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.92063633 |
| 117 | MP0000627_abnormal_mammary_gland | 0.91980018 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 0.91818140 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.91222397 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.91029202 |
| 121 | MP0008872_abnormal_physiological_respon | 0.90368370 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.90251810 |
| 123 | MP0001879_abnormal_lymphatic_vessel | 0.90188760 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89229463 |
| 125 | MP0005174_abnormal_tail_pigmentation | 0.88067156 |
| 126 | MP0003763_abnormal_thymus_physiology | 0.87841968 |
| 127 | MP0005670_abnormal_white_adipose | 0.85915500 |
| 128 | MP0008873_increased_physiological_sensi | 0.85683175 |
| 129 | MP0005384_cellular_phenotype | 0.83871692 |
| 130 | MP0002722_abnormal_immune_system | 0.83719124 |
| 131 | MP0003890_abnormal_embryonic-extraembry | 0.83380068 |
| 132 | MP0000015_abnormal_ear_pigmentation | 0.83192766 |
| 133 | MP0006036_abnormal_mitochondrial_physio | 0.82004039 |
| 134 | MP0005636_abnormal_mineral_homeostasis | 0.81622833 |
| 135 | MP0002132_abnormal_respiratory_system | 0.80485671 |
| 136 | MP0005410_abnormal_fertilization | 0.80223355 |
| 137 | MP0003300_gastrointestinal_ulcer | 0.78592995 |
| 138 | MP0003950_abnormal_plasma_membrane | 0.78226268 |
| 139 | MP0003111_abnormal_nucleus_morphology | 0.77815976 |
| 140 | MP0001756_abnormal_urination | 0.76787239 |
| 141 | MP0009642_abnormal_blood_homeostasis | 0.76353974 |
| 142 | MP0001216_abnormal_epidermal_layer | 0.76304261 |
| 143 | MP0004233_abnormal_muscle_weight | 0.75855536 |
| 144 | MP0002060_abnormal_skin_morphology | 0.75813749 |
| 145 | MP0010352_gastrointestinal_tract_polyps | 0.75808275 |
| 146 | MP0002019_abnormal_tumor_incidence | 0.75120586 |
| 147 | MP0003303_peritoneal_inflammation | 0.74253320 |
| 148 | MP0000613_abnormal_salivary_gland | 0.72487353 |
| 149 | MP0003315_abnormal_perineum_morphology | 0.72031410 |
| 150 | MP0001243_abnormal_dermal_layer | 0.71610417 |
| 151 | MP0002086_abnormal_extraembryonic_tissu | 0.71555082 |
| 152 | MP0005621_abnormal_cell_physiology | 0.70252643 |
| 153 | MP0001661_extended_life_span | 0.70054876 |
| 154 | MP0010771_integument_phenotype | 0.65970149 |
| 155 | MP0002085_abnormal_embryonic_tissue | 0.65654588 |
| 156 | MP0004272_abnormal_basement_membrane | 0.65585831 |
| 157 | MP0002168_other_aberrant_phenotype | 0.64588338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.92697829 |
| 2 | Methylmalonic acidemia (HP:0002912) | 3.89832895 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 3.73902858 |
| 4 | Abnormality of glycolysis (HP:0004366) | 3.71144804 |
| 5 | Cholecystitis (HP:0001082) | 3.66834156 |
| 6 | Abnormal gallbladder physiology (HP:0012438) | 3.66834156 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.62576163 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.59361919 |
| 9 | Methylmalonic aciduria (HP:0012120) | 3.57481574 |
| 10 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45857237 |
| 11 | Increased serum pyruvate (HP:0003542) | 3.45542246 |
| 12 | Meckel diverticulum (HP:0002245) | 3.38805140 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.35993699 |
| 14 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.33032056 |
| 15 | Abnormality of the ileum (HP:0001549) | 3.31571490 |
| 16 | Abnormality of the preputium (HP:0100587) | 3.30616858 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.28726717 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.22915985 |
| 19 | Hepatocellular necrosis (HP:0001404) | 3.22338008 |
| 20 | Chromsome breakage (HP:0040012) | 3.21183448 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 3.19229931 |
| 22 | Acute encephalopathy (HP:0006846) | 3.18878501 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.11900813 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 3.11456379 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.07358495 |
| 26 | Acute necrotizing encephalopathy (HP:0006965) | 3.06196178 |
| 27 | Complement deficiency (HP:0004431) | 3.04285242 |
| 28 | Hepatic necrosis (HP:0002605) | 3.00828950 |
| 29 | Joint hemorrhage (HP:0005261) | 2.99104947 |
| 30 | Microvesicular hepatic steatosis (HP:0001414) | 2.98589065 |
| 31 | Thrombocytosis (HP:0001894) | 2.97477111 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.97444060 |
| 33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.96320904 |
| 34 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.96320904 |
| 35 | Hypoplasia of the pons (HP:0012110) | 2.92868640 |
| 36 | Prolonged partial thromboplastin time (HP:0003645) | 2.90051892 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90008242 |
| 38 | Xanthomatosis (HP:0000991) | 2.89129141 |
| 39 | Abnormality of the pons (HP:0007361) | 2.86440486 |
| 40 | Rough bone trabeculation (HP:0100670) | 2.85326245 |
| 41 | Abnormality of complement system (HP:0005339) | 2.85183240 |
| 42 | * Reduced antithrombin III activity (HP:0001976) | 2.77483821 |
| 43 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.75881275 |
| 44 | Pancytopenia (HP:0001876) | 2.72435096 |
| 45 | Abnormality of DNA repair (HP:0003254) | 2.72400313 |
| 46 | Mitochondrial inheritance (HP:0001427) | 2.71933002 |
| 47 | Increased CSF lactate (HP:0002490) | 2.70017334 |
| 48 | Beaking of vertebral bodies (HP:0004568) | 2.67381002 |
| 49 | Testicular atrophy (HP:0000029) | 2.64981085 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.63750017 |
| 51 | Hyperglycinemia (HP:0002154) | 2.62757598 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.61841507 |
| 53 | Hyperammonemia (HP:0001987) | 2.60965368 |
| 54 | Glomerulonephritis (HP:0000099) | 2.59742005 |
| 55 | Abnormality of methionine metabolism (HP:0010901) | 2.59562158 |
| 56 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.59310490 |
| 57 | CNS demyelination (HP:0007305) | 2.59265833 |
| 58 | Small intestinal stenosis (HP:0012848) | 2.59122325 |
| 59 | Duodenal stenosis (HP:0100867) | 2.59122325 |
| 60 | Late onset (HP:0003584) | 2.58990578 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.56993038 |
| 62 | Hyperlipoproteinemia (HP:0010980) | 2.50660636 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.50508488 |
| 64 | Increased serum lactate (HP:0002151) | 2.49802103 |
| 65 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.46424282 |
| 66 | Recurrent bacterial skin infections (HP:0005406) | 2.45001816 |
| 67 | Cerebral edema (HP:0002181) | 2.42687770 |
| 68 | Abnormality of chromosome stability (HP:0003220) | 2.41729602 |
| 69 | Hyperglycinuria (HP:0003108) | 2.40427900 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38438956 |
| 71 | Hypolipoproteinemia (HP:0010981) | 2.38427123 |
| 72 | Recurrent abscess formation (HP:0002722) | 2.37769281 |
| 73 | Exercise intolerance (HP:0003546) | 2.37619509 |
| 74 | Progressive macrocephaly (HP:0004481) | 2.37298493 |
| 75 | Vascular calcification (HP:0004934) | 2.37239916 |
| 76 | Aplastic anemia (HP:0001915) | 2.37024208 |
| 77 | Abnormality of vitamin B metabolism (HP:0004340) | 2.36083209 |
| 78 | Fat malabsorption (HP:0002630) | 2.35941822 |
| 79 | Palpitations (HP:0001962) | 2.34805217 |
| 80 | Menorrhagia (HP:0000132) | 2.34212811 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.33925734 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33312645 |
| 83 | Mucopolysacchariduria (HP:0008155) | 2.33312645 |
| 84 | Nephritis (HP:0000123) | 2.32490052 |
| 85 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30226430 |
| 86 | Entropion (HP:0000621) | 2.30193086 |
| 87 | Lactic acidosis (HP:0003128) | 2.29341871 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.28783657 |
| 89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28783657 |
| 90 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.27134727 |
| 91 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.27134727 |
| 92 | Single umbilical artery (HP:0001195) | 2.27134727 |
| 93 | Sparse eyelashes (HP:0000653) | 2.27072298 |
| 94 | Nausea (HP:0002018) | 2.26659191 |
| 95 | Autoimmune thrombocytopenia (HP:0001973) | 2.26600273 |
| 96 | Abnormal gallbladder morphology (HP:0012437) | 2.25515696 |
| 97 | Cerebral hypomyelination (HP:0006808) | 2.25352341 |
| 98 | Basal ganglia calcification (HP:0002135) | 2.24394350 |
| 99 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.23769697 |
| 100 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.23769697 |
| 101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.23769697 |
| 102 | Petechiae (HP:0000967) | 2.22612634 |
| 103 | Epistaxis (HP:0000421) | 2.21648747 |
| 104 | Abnormal platelet function (HP:0011869) | 2.21237490 |
| 105 | Impaired platelet aggregation (HP:0003540) | 2.21237490 |
| 106 | Abnormal trabecular bone morphology (HP:0100671) | 2.20931305 |
| 107 | Abnormality of the umbilical cord (HP:0010881) | 2.20620396 |
| 108 | Myelodysplasia (HP:0002863) | 2.20402185 |
| 109 | Cholelithiasis (HP:0001081) | 2.19337791 |
| 110 | Esophageal varix (HP:0002040) | 2.18474766 |
| 111 | Polycythemia (HP:0001901) | 2.18316803 |
| 112 | Vertebral compression fractures (HP:0002953) | 2.16888910 |
| 113 | Cardiovascular calcification (HP:0011915) | 2.16093048 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12695251 |
| 115 | Ketosis (HP:0001946) | 2.11035041 |
| 116 | Abnormality of nucleobase metabolism (HP:0010932) | 2.10490071 |
| 117 | Lethargy (HP:0001254) | 2.10263245 |
| 118 | Opisthotonus (HP:0002179) | 2.10121433 |
| 119 | IgM deficiency (HP:0002850) | 2.10085034 |
| 120 | Hypoglycemic seizures (HP:0002173) | 2.10020049 |
| 121 | Steatorrhea (HP:0002570) | 2.09343007 |
| 122 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.08669548 |
| 123 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.07701824 |
| 124 | Gingival bleeding (HP:0000225) | 2.07367183 |
| 125 | * Abnormal protein glycosylation (HP:0012346) | 2.07065193 |
| 126 | * Abnormal glycosylation (HP:0012345) | 2.07065193 |
| 127 | * Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.07065193 |
| 128 | * Abnormal protein N-linked glycosylation (HP:0012347) | 2.07065193 |
| 129 | Myocardial infarction (HP:0001658) | 2.05760490 |
| 130 | Spontaneous hematomas (HP:0007420) | 2.05620687 |
| 131 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.05570050 |
| 132 | Abnormality of glycine metabolism (HP:0010895) | 2.05570050 |
| 133 | Abnormality of the duodenum (HP:0002246) | 2.04597320 |
| 134 | Abnormality of homocysteine metabolism (HP:0010919) | 2.04385956 |
| 135 | Homocystinuria (HP:0002156) | 2.04385956 |
| 136 | Nonimmune hydrops fetalis (HP:0001790) | 2.03560757 |
| 137 | Biconcave vertebral bodies (HP:0004586) | 2.02693190 |
| 138 | Hypoalphalipoproteinemia (HP:0003233) | 2.01848552 |
| 139 | Purpura (HP:0000979) | 2.01010534 |
| 140 | * Type I transferrin isoform profile (HP:0003642) | 2.00600237 |
| 141 | Abnormality of macrophages (HP:0004311) | 1.99522400 |
| 142 | Pancreatitis (HP:0001733) | 1.97614731 |
| 143 | Abnormal number of erythroid precursors (HP:0012131) | 1.97406819 |
| 144 | Abnormality of vitamin metabolism (HP:0100508) | 1.96439374 |
| 145 | Dysostosis multiplex (HP:0000943) | 1.95296793 |
| 146 | Cortical dysplasia (HP:0002539) | 1.93604060 |
| 147 | Megaloblastic anemia (HP:0001889) | 1.93512447 |
| 148 | Oral leukoplakia (HP:0002745) | 1.93326202 |
| 149 | Abnormality of the gallbladder (HP:0005264) | 1.91442241 |
| 150 | Ragged-red muscle fibers (HP:0003200) | 1.91012309 |
| 151 | Hypokinesia (HP:0002375) | 1.89252014 |
| 152 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.88759885 |
| 153 | Neoplasm of the adrenal gland (HP:0100631) | 1.88640478 |
| 154 | Clubbing of toes (HP:0100760) | 1.88327182 |
| 155 | Reticulocytopenia (HP:0001896) | 1.87813522 |
| 156 | Adrenal hypoplasia (HP:0000835) | 1.87279376 |
| 157 | Spastic paraparesis (HP:0002313) | 1.86397704 |
| 158 | Poor head control (HP:0002421) | 1.85046107 |
| 159 | Secondary amenorrhea (HP:0000869) | 1.84462168 |
| 160 | Prolonged bleeding time (HP:0003010) | 1.84070441 |
| 161 | Myositis (HP:0100614) | 1.82758285 |
| 162 | Degeneration of anterior horn cells (HP:0002398) | 1.82127061 |
| 163 | Abnormality of the anterior horn cell (HP:0006802) | 1.82127061 |
| 164 | Cervical subluxation (HP:0003308) | 1.81833276 |
| 165 | Respiratory failure (HP:0002878) | 1.80997774 |
| 166 | Renal Fanconi syndrome (HP:0001994) | 1.80776826 |
| 167 | Horseshoe kidney (HP:0000085) | 1.79992337 |
| 168 | Periodontitis (HP:0000704) | 1.79836565 |
| 169 | Bone marrow hypocellularity (HP:0005528) | 1.79200121 |
| 170 | Myopathic facies (HP:0002058) | 1.78714940 |
| 171 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.78632473 |
| 172 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.78604855 |
| 173 | Premature ovarian failure (HP:0008209) | 1.76930588 |
| 174 | Oligomenorrhea (HP:0000876) | 1.76855712 |
| 175 | Gout (HP:0001997) | 1.76706496 |
| 176 | Abnormal lung lobation (HP:0002101) | 1.75698802 |
| 177 | Epiphyseal stippling (HP:0010655) | 1.73979003 |
| 178 | Emotional lability (HP:0000712) | 1.72270259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.34463206 |
| 2 | ERN1 | 4.37776956 |
| 3 | BRSK2 | 3.20786227 |
| 4 | MST4 | 2.99426558 |
| 5 | STK16 | 2.83200024 |
| 6 | TSSK6 | 2.81745786 |
| 7 | BCKDK | 2.73696290 |
| 8 | NME2 | 2.72435738 |
| 9 | EPHA3 | 2.62745703 |
| 10 | IRAK4 | 2.49909185 |
| 11 | TTK | 2.37103764 |
| 12 | FLT3 | 2.35121276 |
| 13 | CAMKK2 | 2.33796838 |
| 14 | BLK | 2.26536634 |
| 15 | EPHA2 | 2.12188478 |
| 16 | KDR | 2.07860055 |
| 17 | NME1 | 2.05451787 |
| 18 | PLK3 | 1.93585005 |
| 19 | MAP4K1 | 1.91108627 |
| 20 | ZAP70 | 1.84364174 |
| 21 | TRIB3 | 1.84187346 |
| 22 | PKN2 | 1.78163495 |
| 23 | PDK2 | 1.72223180 |
| 24 | PBK | 1.71525883 |
| 25 | BUB1 | 1.71355026 |
| 26 | IRAK3 | 1.70209516 |
| 27 | TGFBR1 | 1.65636889 |
| 28 | BRD4 | 1.64596491 |
| 29 | TGFBR2 | 1.61535327 |
| 30 | EIF2AK1 | 1.57734826 |
| 31 | TRIM28 | 1.55597321 |
| 32 | RPS6KA4 | 1.55084567 |
| 33 | TIE1 | 1.52883872 |
| 34 | BRSK1 | 1.50386449 |
| 35 | TAOK2 | 1.48271002 |
| 36 | PIM2 | 1.45827271 |
| 37 | ZAK | 1.45330605 |
| 38 | MKNK1 | 1.43762856 |
| 39 | BTK | 1.35651514 |
| 40 | KIT | 1.31936595 |
| 41 | TYK2 | 1.29681701 |
| 42 | WEE1 | 1.29566784 |
| 43 | EIF2AK3 | 1.28151347 |
| 44 | ABL2 | 1.27449954 |
| 45 | LIMK1 | 1.24997010 |
| 46 | TBK1 | 1.23457020 |
| 47 | TEC | 1.18868027 |
| 48 | JAK3 | 1.10055257 |
| 49 | LATS1 | 1.09997077 |
| 50 | INSRR | 1.09658643 |
| 51 | SMG1 | 1.09146521 |
| 52 | PAK4 | 1.07647197 |
| 53 | NEK9 | 1.06614459 |
| 54 | MAP2K3 | 1.03134205 |
| 55 | MAP4K2 | 1.02548582 |
| 56 | TAF1 | 1.02208276 |
| 57 | TAOK3 | 0.99806585 |
| 58 | PASK | 0.98435133 |
| 59 | FGFR4 | 0.98390812 |
| 60 | CDC7 | 0.98118711 |
| 61 | CCNB1 | 0.96405009 |
| 62 | PIM1 | 0.94947276 |
| 63 | DAPK1 | 0.93903007 |
| 64 | CSNK1G3 | 0.93441709 |
| 65 | TRPM7 | 0.92516207 |
| 66 | PRKCI | 0.91364277 |
| 67 | PTK6 | 0.91051825 |
| 68 | CHEK2 | 0.90367921 |
| 69 | TESK2 | 0.89400515 |
| 70 | MAPKAPK5 | 0.89256625 |
| 71 | PLK4 | 0.86059365 |
| 72 | LYN | 0.85306104 |
| 73 | SRPK1 | 0.85233410 |
| 74 | NEK1 | 0.85093190 |
| 75 | MAP3K14 | 0.84979346 |
| 76 | SIK3 | 0.83433600 |
| 77 | CSF1R | 0.82764138 |
| 78 | MAP3K11 | 0.80858960 |
| 79 | NEK2 | 0.80828044 |
| 80 | ACVR1B | 0.80826858 |
| 81 | CLK1 | 0.79505886 |
| 82 | LRRK2 | 0.78145577 |
| 83 | CSNK1A1L | 0.77572314 |
| 84 | WNK3 | 0.77182331 |
| 85 | CDK4 | 0.76931494 |
| 86 | IRAK2 | 0.74714235 |
| 87 | TXK | 0.73020733 |
| 88 | PRPF4B | 0.72007288 |
| 89 | PIK3CG | 0.70847082 |
| 90 | CDK7 | 0.69076944 |
| 91 | FER | 0.66519860 |
| 92 | MAP3K12 | 0.64712076 |
| 93 | ERBB4 | 0.63873913 |
| 94 | IKBKE | 0.63575457 |
| 95 | EEF2K | 0.63231974 |
| 96 | MAPKAPK3 | 0.62960487 |
| 97 | IKBKB | 0.62608576 |
| 98 | SYK | 0.61527254 |
| 99 | MATK | 0.59087350 |
| 100 | STK4 | 0.58761598 |
| 101 | RPS6KB2 | 0.58597009 |
| 102 | MAPK11 | 0.58458650 |
| 103 | VRK1 | 0.58382580 |
| 104 | PDGFRA | 0.57547466 |
| 105 | STK10 | 0.57541309 |
| 106 | CSNK1G1 | 0.56901060 |
| 107 | AURKB | 0.56681108 |
| 108 | CHEK1 | 0.55867439 |
| 109 | SIK1 | 0.55717290 |
| 110 | AURKA | 0.54013632 |
| 111 | CSNK2A1 | 0.51430993 |
| 112 | ATM | 0.51320134 |
| 113 | TESK1 | 0.50329290 |
| 114 | MKNK2 | 0.50025939 |
| 115 | ATR | 0.49777009 |
| 116 | MST1R | 0.48944252 |
| 117 | NLK | 0.48607905 |
| 118 | MAP3K3 | 0.48343685 |
| 119 | CDK6 | 0.47089337 |
| 120 | CSNK1G2 | 0.46736442 |
| 121 | BCR | 0.46714815 |
| 122 | ILK | 0.46285697 |
| 123 | CSNK2A2 | 0.46280219 |
| 124 | MYLK | 0.46256835 |
| 125 | LMTK2 | 0.45147093 |
| 126 | CDK8 | 0.44082845 |
| 127 | CHUK | 0.42803315 |
| 128 | PRKG2 | 0.42767487 |
| 129 | EIF2AK2 | 0.42323441 |
| 130 | MAP3K8 | 0.41888337 |
| 131 | PAK1 | 0.40218018 |
| 132 | MARK3 | 0.40134512 |
| 133 | MAPKAPK2 | 0.39479266 |
| 134 | ERBB3 | 0.38755670 |
| 135 | JAK2 | 0.38714121 |
| 136 | PTK2 | 0.37781405 |
| 137 | MET | 0.37277058 |
| 138 | PLK1 | 0.37171819 |
| 139 | SCYL2 | 0.37055253 |
| 140 | STK24 | 0.36442577 |
| 141 | JAK1 | 0.36270899 |
| 142 | LCK | 0.35743058 |
| 143 | NUAK1 | 0.35319249 |
| 144 | MAP3K5 | 0.32990766 |
| 145 | CSNK1A1 | 0.31086003 |
| 146 | GRK1 | 0.29659638 |
| 147 | RPS6KA5 | 0.27771998 |
| 148 | YES1 | 0.27296706 |
| 149 | PRKDC | 0.27021727 |
| 150 | PLK2 | 0.27009938 |
| 151 | MUSK | 0.25217255 |
| 152 | CDK1 | 0.24367793 |
| 153 | BRAF | 0.22910308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.62225799 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.20866823 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.15226126 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.13016739 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11734372 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09254204 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05394767 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.04577310 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.03086125 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02932968 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.01489512 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.95283716 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92648650 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89684567 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.84503723 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 1.79592348 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.76327731 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.72834600 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.69632898 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.66935497 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.66313728 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60694163 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.58160004 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57034263 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52521317 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.52472727 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52082201 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.50789737 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37527121 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.36892486 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.36709560 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.34967934 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.33751727 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30230559 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.28078038 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27680120 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24345459 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23232379 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22647262 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20686862 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20623833 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20533897 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15612763 |
| 44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.14290453 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13048877 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11200064 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10135012 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09986444 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.09844794 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09498446 |
| 51 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06155982 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05406008 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04156136 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.04017450 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.99787531 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99106503 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98950755 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.98687487 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98129864 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94153822 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.93015567 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91793585 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91598603 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.91480500 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91370936 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91012341 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89287684 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.88374264 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88051211 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86875190 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84254981 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.83901236 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83161516 |
| 74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.82050618 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80401619 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78112782 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76840773 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75028794 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74240358 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74063683 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.72518709 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72135676 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70506565 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70232203 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.70211419 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69371763 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66939585 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65326021 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63547622 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61312600 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60830793 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58344670 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57737003 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56826097 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | 0.56507057 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56231818 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.55752803 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55331010 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.53784509 |
| 100 | RNA transport_Homo sapiens_hsa03013 | 0.53489605 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52516158 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51271660 |
| 103 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50556335 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49085225 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49031857 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46911535 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.45189858 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44954820 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43597768 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42513642 |
| 111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42167650 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40504020 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.40188084 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39952391 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39597306 |
| 116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39439010 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38387760 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37635657 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36912043 |
| 120 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35937577 |
| 121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35762644 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32978483 |
| 123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26274325 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25410287 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24568146 |

